Combination Therapy with Abatacept and Daratumumab in Patients with Active Rheumatoid Arthritis: Phase I Results of the CURACTA Trial (ACR Convergence 2026) - Sep 8, 2026 - Abstract #1402; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Combination therapy • P1 data • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
|